Document is current
Any future updates will be listed below
-
Authors
Sasso, Ferdinando Carlo https://orcid.org/0000-0002-9142-7848
Pafundi, Pia Clara
Simeon, Vittorio
De Nicola, Luca
Chiodini, Paolo
Galiero, Raffaele
Rinaldi, Luca
Nevola, Riccardo
Salvatore, Teresa
Sardu, Celestino
Marfella, Raffaele
Adinolfi, Luigi Elio
Minutolo, Roberto
,
Amelia, U.
Acierno, C.
Calatola, P.
Carbonara, O.
Caturano, A.
Conte, G.
Corigliano, G.
Corigliano, M.
D’Urso, R.
De Matteo, A.
De Nicola, L.
De Rosa, N.
Del Vecchio, E.
Di Giovanni, G.
Gatti, A.
Gentile, S.
Gesuè, L.
Improta, L.
Lampitella, A. Jr
Lampitella, A.
Lanzilli, A.
Lascar, N.
Masi, S.
Mattei, P.
Mastrilli, V.
Memoli, P.
Minutolo, R.
Nasti, R.
Pagano, A.
Pentangelo, M.
Pisa, E.
Rossi, E.
Sasso, F. C.
Sorrentino, S.
Torella, R.
Troise, R.
Trucillo, P.
Turco, A. A.
Turco, S.
Zibella, F.
Zirpoli, L.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00535925 at ClinicalTrials.govDocuments that mention this clinical trial
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease
https://doi.org/10.1186/s12933-021-01343-1
-
Funding
Funding for this research was provided by:
Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2007)
- License Information
-
More Information
Article History
Received: 16 May 2021
Accepted: 9 July 2021
First Online: 16 July 2021
Declarations
:
: The trial was conducted in accordance with the guiding principles of the Declaration of Helsinki and was approved by the local ethics committee.
: Not applicable.
: Luca De Nicola has received fees for scientific consultation and/or lectures by Astellas, AstraZeneca, Mundibiopharma and Vifor Pharma. Roberto Minutolo has been member of Advisory Boards for Astellas, and invited speaker at meetings supported by Amgen, Vifor Pharma. Ferdinando Carlo Sasso has been member of Advisory Boards for Boehringer and for Ely-Lilly and has received fees for scientific consultation and/or lectures by Jansen, Roche Diagnostics, Novo Nordisk, Sanofi, MSD, Astrazeneca. Pia Clara Pafundi, Vittorio Simeon, Paolo Chiodini, Raffaele Galiero, Luca Rinaldi, Riccardo Nevola, Teresa Salvatore, Raffaele Marfella, Celestino Sardu, and Luigi Elio Adinolfi have no conflict of interest to disclose.
